Achieve Life Sciences, Inc.
NASDAQ:ACHV · NASDAQ Capital Market
-$0.38 today
Vol 4.48M · Avg 1.44M
Filings
Ground the analysis in primary documents
Pair price history with recent company filings so you can connect market moves to the actual disclosures behind the business.
Price History
Dividend-adjusted closing price
Change
+26.30%
Period High
$5.99
Period Low
$2.07
Latest
$4.85
SEC Filings
Recent regulatory filings
No filings found.
Competitors
Peer companies in the same sector
Capricor Therapeutics, Inc.
NASDAQ:CAPR
$1.29B
Allogene Therapeutics, Inc.
NASDAQ:ALLO
$485.30M
Vanda Pharmaceuticals Inc.
NASDAQ:VNDA
$346.38M
Atea Pharmaceuticals, Inc.
NASDAQ:AVIR
$344.52M
Entrada Therapeutics, Inc.
NASDAQ:TRDA
$266.50M
Voyager Therapeutics, Inc.
NASDAQ:VYGR
$223.26M
Sagimet Biosciences Inc.
NASDAQ:SGMT
$217.64M
Arcturus Therapeutics Holdings Inc.
NASDAQ:ARCT
$211.33M
Immuneering Corporation
NASDAQ:IMRX
$156.64M
Humacyte, Inc.
NASDAQ:HUMA
$154.02M
What is the latest ACHV filing?
The latest filing shown is ARS dated Jun 8, 2026.
How many recent filings does ACHV have?
Intrinsic Alpha currently shows 20 recent filings for ACHV.
Explore More
Continue the stock analysis
Jump to another research area for this company.